Article
Diagnostic performance of aPS/PT antibodies in neuropsychiatric lupus and cardiovascular complications of systemic lupus erythematosus.
Autoimmunity - 1 Feb 2020
Ramirez Giuseppe A, Canti Valentina, Del Rosso Stefania, Erra Roberta, Moiola Lucia, Magnoni Marco, Bozzolo Enrica P, Manfredi Angelo A, Rovere-Querini Patrizia
Abstract excerpt
Background: Systemic lupus erythematosus (SLE) is associated with a constellation of complications affecting multiple organs, including neuropsychiatric manifestations (NPSLE) and ischaemic events, leading to increased long-term morbidity. Antiphospholipid antibodies (aPL) are a major determinant of vascular inflammation and thromboembolic risk. The diagnostic role of anti-phosphatidylserine/prothrombin (aPS/PT)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.